Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 1/20 | 0.47 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.47 |
| ▸ | THPO | P40225 | 1/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.47 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.47 |
| ▸ | TYR | P14679 | 3/20 | 0.47 |
| ▸ | HPSE | Q9Y251 | 1/20 | 0.45 |
| ▸ | AMY2A | P04746 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6514488 | 1.00 | CYP1A2 (0.47) | CYP1A2NFKB1THPOALDH1A1PMP22 | |
| SCHEMBL9806246 | 0.98 | TYR (0.48) | CYP1A2NFKB1THPOALDH1A1PMP22 | |
| SCHEMBL6873455 | 0.93 | CYP1A2 (0.46) | CYP1A2NFKB1THPOALDH1A1PMP22 | |
| SCHEMBL8313911 | 0.92 | CYP1A2 (0.47) | CYP1A2NFKB1THPOALDH1A1PMP22 | |
| SCHEMBL5831825 | 0.92 | CYP1A2 (0.47) | CYP1A2NFKB1THPOALDH1A1PMP22 | |
| SCHEMBL8315726 | 0.92 | CYP1A2 (0.47) | CYP1A2NFKB1THPOALDH1A1PMP22 | |
| SCHEMBL9563939 | 0.92 | CYP1A2 (0.47) | CYP1A2NFKB1THPOALDH1A1PMP22 | |
| SCHEMBL7958087 | 0.90 | TYR (0.57) | CYP1A2NFKB1THPOALDH1A1PMP22 | |
| SCHEMBL5831830 | 0.90 | TYR (0.57) | CYP1A2NFKB1THPOALDH1A1PMP22 | |
| SCHEMBL10653843 | 0.90 | TYR (0.57) | CYP1A2NFKB1THPOALDH1A1PMP22 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2428578-A1 | GLUCURONIC ACID-CONTAINING GLUCAN, PROCESS FOR PRODUCTION OF SAME, AND USE OF SAME | National University Corporation Kagoshima University (JP) | 2012-03-14 | — | — | EP | claimed |
| EP-2636749-B1 | NON-REDUCING END-MODIFIED GLUCAN, METHOD FOR PRODUCING SAME, AND USE THEREOF | EZAKI GLICO CO (JP) | 2016-08-03 | — | — | EP | disclosed |
| EP-2428578-B1 | GLUCURONIC ACID-CONTAINING GLUCAN, PROCESS FOR PRODUCTION OF SAME, AND USE OF SAME | EZAKI GLICO CO (JP) | 2016-03-23 | — | — | EP | disclosed |
| US-20130302405-A1 | AMINO SUGAR-CONTAINING GLUCAN, METHOD FOR PRODUCING SAME, AND USE THEREOF | EZAKI GLICO CO., LTD. (JP) | 2013-11-14 | — | — | US | disclosed |
| US-20130295163-A1 | NON-REDUCING END MODIFIED GLUCAN, METHOD FOR PRODUCING SAME, AND USE THEREOF | EZAKI GLICO CO., LTD. (JP) | 2013-11-07 | — | — | US | disclosed |
| US-8575131-B2 | Glucuronic acid-containing glucan, process for production of same, and use of same | NATIONAL UNIVERSITY CORPORATION KAGOSHIMA UNIVERSITY (JP) | 2013-11-05 | — | — | US | disclosed |
| EP-2636749-A1 | NON-REDUCING END-MODIFIED GLUCAN, METHOD FOR PRODUCING SAME, AND USE THEREOF | Ezaki Glico Co., Ltd. (JP) | 2013-09-11 | — | — | EP | disclosed |
| EP-2636748-A1 | AMINO SUGAR-CONTAINING GLUCAN, METHOD FOR PRODUCING SAME AND USE OF SAME | Ezaki Glico Co., Ltd. (JP) | 2013-09-11 | — | — | EP | disclosed |
| US-20120135063-A1 | GLUCURONIC ACID-CONTAINING GLUCAN, PROCESS FOR PRODUCTION OF SAME, AND USE OF SAME | EZAKI GLICO CO., LTD. (JP) | 2012-05-31 | — | — | US | disclosed |
| EP-2428578-A1 | GLUCURONIC ACID-CONTAINING GLUCAN, PROCESS FOR PRODUCTION OF SAME, AND USE OF SAME | National University Corporation Kagoshima University (JP) | 2012-03-14 | — | — | EP | disclosed |
| US-20060236426-A1 | Nucleic acid molecules encoding starch degrading enzymes | MAX-PLANCK-GESELLSCHAFT ZUR FORDERUNG DER WISSENSCHAFTEN E.V. (DE) | 2006-10-19 | — | — | US | disclosed |
| EP-1381676-A2 | NUCLEIC ACID MOLECULES ENCODING STARCH DEGRADING ENZYMES | MAX-PLANCK-GESELLSCHAFT ZUR FÖRDERUNG DER WISSENSCHAFTEN E.V. (DE) | 2004-01-21 | — | — | EP | disclosed |
| US-20030175843-A1 | Reagent, method and apparatus for measuring amylase activity | TOYAMA UNIVERSITY (JP) | 2003-09-18 | — | — | US | disclosed |
| US-20030175842-A1 | Kit which uses maltose and chromogens to quantify hydrolase activity and diagnose pancreatic, kidney, liver or tumor disorders | TOYAMA UNIVERSITY (JP) | 2003-09-18 | — | — | US | disclosed |
| EP-1342790-A2 | Reagent and method for measuring amylase activity | Toyama University (JP) | 2003-09-10 | — | — | EP | disclosed |
| EP-1342791-A2 | Reagent, method and apparatus for measuring amylase activity | Toyama University (JP) | 2003-09-10 | — | — | EP | disclosed |
| US-20030135878-A1 | Transgenic plants with elevated thioredoxin levels | REGENTS OF THE UNIVERSITY OF CALIFORNIA, THE | 2003-07-17 | — | — | US | disclosed |
| WO-2002086112-A2 | NUCLEIC ACID MOLECULES ENCODING STARCH DEGRADING ENZYMES | MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) | 2002-10-31 | — | — | WO | disclosed |
| EP-0173255-B1 | OLIGOSACCHARIDE DERIVATIVES AND THEIR USE AS SUBSTRATE FOR MEASURING ALPHA-AMYLASE ACTIVITY | WAKO PURE CHEMICAL INDUSTRIES, LTD. (JP) | 1991-04-17 | — | — | EP | disclosed |
| US-4683198-A | DOES NOT REQUIRE NAD OR NADP | TOYO JOZO KABUSHIKI KAISHA (JP) | 1987-07-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130302405-A1 | AMINO SUGAR-CONTAINING GLUCAN, METHOD FOR PRODUCING SAME, AND USE THEREOF | GALE, MGAM, ENGASE | CYP1A2 3606/4885NFKB1 1440/4885THPO 2553/4885 |
| US-20120135063-A1 | GLUCURONIC ACID-CONTAINING GLUCAN, PROCESS FOR PRODUCTION OF SAME, AND USE OF SAME | ENGASE, FUCA1, ALG8 | CYP1A2 1744/4885NFKB1 1375/4885THPO 3214/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.